Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique

Laboratory Animals

Volumn 39, Issue 3, 2005, Pages 336-352

  Guilbault, C ^a   Martin, P ^a   Houle, D ^a   Boghdady, M L ^a   Guiot, M C ^b   Marion, D ^a   Radzioch, Danuta ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Agar beads; Cftr knockout; Lung infection; Mice; Pseudomonas aeruginosa

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL HOUSING; ANIMAL MODEL; ANIMAL TESTING ALTERNATIVE; ANIMAL TISSUE; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; INFECTION SENSITIVITY; INFLAMMATION; INOCULATION; KNOCKOUT MOUSE; LUNG ALVEOLUS CELL; LUNG INFECTION; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE; TECHNIQUE; TRACHEA; TRACHEOTOMY; WEIGHT REDUCTION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE; CYSTIC FIBROSIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MALE; MICE; MICE, INBRED CFTR; MICROSPHERES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

ANIMALIA; PSEUDOMONAS AERUGINOSA; RODENTIA;

EID: 23044513108     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/0023677054306944     Document Type: Article

References (46)

1. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH (1995) IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. Journal of Immunology 154, 483-90
2. Bonfield TL, Panuska JR, Konstan MW, et al. (1995) Inflammatory cytokines in cystic fibrosis lungs. American Journal of Respiratory and Critical Care Medicine 152, 2111-18
3. [Erratum (1996): American Journal of Respiratory and Critical Care Medicine 154 (4 Pt 1), following 1217]
4. Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA (1979) A rat model of chronic respiratory infection with Pseudomonas aeruginosa. American Journal of Respiratory Disease 119, 453-9
5. Chroneos ZC, Wert SE, Livingston JL, Hassett DJ, Whitsett JA (2000) Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo. Journal of Immunology 165, 3941-50
6. Colledge WH, Abella BS, Southern KW, et al. (1995) Generation and characterization of a delta F508 cystic fibrosis mouse model. Nature Genetics 10, 445-52
7. Davidson DJ, Dorin JR, McLachlan G, et al. (1995) Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genetics 9, 351-7
8. Delaney SJ, Alton EW, Smith SN, et al. (1996) Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO Journal 15, 955-63
9. Dosanjh AK, Elashoff D, Robbins RC (1998) The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. Journal of Interferon Cytokine Research 18, 851-4
10. Dunn MM, Toews GB, Hart D, Pierce AK (1985) The effects of systemic immunization of pulmonary clearance of Pseudomonas aeruginosa. American Review of Respiratory Disease 131, 426-31
11. French PJ, van Doorninck JH, Peters RH, et al. (1996) A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. Journal of Clinical Investigation 98, 1304-12
12. Gandhi R, Elble RC, Gruber AD, et al. (1998) Molecular and functional characterization of a calcium-sensitive chloride channel from mouse lung. Journal of Biological Chemistry 273, 32096-101
13. Giri JG, Ahdieh M, Eisenman J, et al. (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal 13, 2822-30
14. Giri JG, Kumaki S, Ahdieh M, et al. (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO Journal 14, 3654-63
15. Gosselin D, DeSanctis J, Boule M, Skamene E, Matouk C, Radzioch D (1995) Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infection and Immunity 63, 3272-8
16. Gosselin D, Stevenson MM, Cowley EA, et al. (1998) Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. American Journal of Respiratory and Critical Care Medicine 157, 1253-62
17. Grabstein KH, Eisenman J, Shanebeck K, et al. (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264, 965-8
18. Guilbault C, Stotland P, Lachance C, et al. (2002) Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 107, 297-305
19. Hauber HP, Manoukian JJ, Nguyen LH, et al. (2003) Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope 113, 1037-42
20. Hauber HP, Tsicopoulos A, Wallaert B, et al. (2004) Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction. European Respiratory Journal 23, 846-50
21. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T (1997a) Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. Journal of Clinical Investigation 100, 2810-15
22. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T (1997b) Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. Journal of Clinical Investigation 100, 2810-15
23. Jackson AE, Southern PM, Pierce AK, Fallis BD, Sanford JP (1967) Pulmonary clearance of Gram-negative bacilli. Journal of Laboratory and Clinical Medicine 69, 833-41
24. Johnson LG, Boyles SE, Wilson J, Boucher RC (1995) Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. Journal of Clinical Investigation 95, 1377-1382
25. Keller CE, Elliott TB, Bentzel DE, Mog SR, Shoemaker MO, Knudson GB (2003) Susceptibility of irradiated B6D2F1/J mice to Klebsiella pneumoniae administered intratracheally: a pulmonary infection model in an immunocompromised host. Comparative Medicine 53, 397-403
26. Kent G, Iles R, Bear CE, et al. (1997) Lung disease in mice with cystic fibrosis. Journal of Clinical Investigation 100, 3060-9
27. Lewko WM, Smith TL, Bowman DJ, Good RW, Oldham RK (1995) Interleukin-15 and the growth of tumor derived activated T-cells. Cancer Biotherapy 10, 13-20
28. McCray Jr PB, Zabner J, Jia HP, Welsh MJ, Thorne PS (1999) Efficient killing of inhaled bacteria in DeltaF508 mice: role of airway surface liquid composition. American Journal of Physiology 277, L183-90
29. McMorran BJ, Palmer JS, Lunn DP, et al. (2001) G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology 281, L740-7
30. Morissette C, Francoeur C, Darmond-Zwaig C, Gervais F (1996) Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa. Infection and Immunity 64, 4984-92
31. Nelson A, Guilbault C, Radzioch D (2003) Animal models used for the study of cystic fibrosis. In: Recent Research Developments in Cell Research. Research Signpost; Kerala, India, 1, 91-130
32. O'Neal WK, Hasty P, McCray Jr PB, et al. (1993) A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Human Molecular Genetics 2, 1561-9
33. Sadikot RT, Christman JW, Blackwell TS (2004) Molecular targets for modulating lung inflammation and injury. Current Drug Targets 5, 581-8
34. Schook LB, Carrick Jr L, Berk RS (1977) Experimental pulmonary infection of mice by tracheal intubation of Pseudomonas aeruginosa: the use of antineoplastic agents to overcome natural resistance. Canadian Journal of Microbiology 23, 823-6
35. Snouwaert JN, Brigman KK, Latour AM, et al. (1992) An animal model for cystic fibrosis made by gene targeting. Science 257, 1083-8
36. Sokol PA, Sajjan U, Visser MB, Gingues S, Forstner J, Kooi C (2003) The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology 149, 3649-58
37. Southern PM Jr, Mays BB, Pierce AK, Sanford JP (1970) Pulmonary clearance of Pseudomonas aeruginosa. Journal of Laboratory and Clinical Medicine 76, 548-59
38. Starke JR, Edwards MS, Langston C, Baker CJ (1987) A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatric Research 22, 698-702
39. Stotland PK, Radzioch D, Stevenson MM (2000) Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatric Pulmonology 30, 413-24
40. Urban TA, Griffith A, Torok AM, Smolkin ME, Burns JL, Goldberg JB (2004) Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infection and Immunity 72, 5126-34
41. van Doorninck JH, French PJ, Verbeek E, et al. (1995) A mouse model for the cystic fibrosis delta F508 mutation. EMBO Journal 14, 4403-11
42. van Heeckeren AM, Schluchter MD (2002) Murine models of chronic Pseudomonas aeruginosa lung infection. Laboratory Animals 36, 291-312
43. Van Heeckeren AM, Tscheikuna J, Walenga RW, et al. (2000) Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. American Journal of Respiratory and Critical Care Medicine 161, 271-9
44. Weksler B, Ng B, Lenert J, Burt M (1994) A simplified method for endotracheal intubation in the rat. Journal of Applied Physiology 76, 1823-5
45. Yu H, Hanes M, Chrisp CE, Boucher JC, Deretic V (1998) Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infection and Immunity 66, 280-8
46. Zeiher BG, Eichwald E, Zabner J, et al. (1995) A mouse model for the delta F508 allele of cystic fibrosis. Journal of Clinical Investigation 96, 2051-64